These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32318971)

  • 41. Gout in a rheumatology clinic: results of EULAR/ACR guidelines-compliant treatment.
    Slot O
    Scand J Rheumatol; 2018 May; 47(3):194-197. PubMed ID: 28891365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians.
    Qaseem A; Harris RP; Forciea MA; ; Denberg TD; Barry MJ; Boyd C; Chow RD; Humphrey LL; Kansagara D; Vijan S; Wilt TJ
    Ann Intern Med; 2017 Jan; 166(1):58-68. PubMed ID: 27802508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current and future therapies for gout.
    Pascart T; Richette P
    Expert Opin Pharmacother; 2017 Aug; 18(12):1201-1211. PubMed ID: 28689430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 46. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout.
    Nuki G
    Curr Opin Rheumatol; 2014 Mar; 26(2):152-61. PubMed ID: 24492863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.
    Vargas-Santos AB; Castelar-Pinheiro Gda R; Coutinho ES; Schumacher HR; Singh JA; Schlesinger N
    PLoS One; 2015; 10(8):e0135805. PubMed ID: 26274585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacist-managed titration of urate-lowering therapy to streamline gout management.
    Huang IJ; Liew JW; Morcos MB; Zuo S; Crawford C; Bays AM
    Rheumatol Int; 2019 Sep; 39(9):1637-1641. PubMed ID: 31147732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
    Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
    BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New developments in gout.
    Harrold L
    Curr Opin Rheumatol; 2013 May; 25(3):304-9. PubMed ID: 23466959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Febuxostat in the treatment of gout patients with low serum uric acid level: 1-year finding of efficacy and safety study.
    Shen M; Zhang J; Qian K; Li C; Xu W; Gu B; Wang X; Ren Q; Yang L; Yuan H; Su D; Chen X
    Clin Rheumatol; 2018 Nov; 37(11):3107-3113. PubMed ID: 30196323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
    Christensen HD; Sheta HM; Morillon MB; Hansen IM
    Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.
    Harrold LR; Mazor KM; Negron A; Ogarek J; Firneno C; Yood RA
    Rheumatology (Oxford); 2013 Sep; 52(9):1623-9. PubMed ID: 23620554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Quality of treatment in gouty patients considering EULAR recommendations].
    Radak-Perović M; Zlatković-Svenda M
    Srp Arh Celok Lek; 2012; 140(11-12):717-21. PubMed ID: 23350244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical appraisal of serum urate targets in the management of gout.
    Stamp LK; Dalbeth N
    Nat Rev Rheumatol; 2022 Oct; 18(10):603-609. PubMed ID: 35974164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A survey on the beliefs and knowledge of gout management in new medical graduates - New South Wales, Australia.
    Terrill M; Riordan J
    Int J Rheum Dis; 2018 Feb; 21(2):517-522. PubMed ID: 28544467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2016 updated EULAR evidence-based recommendations for the management of gout.
    Richette P; Doherty M; Pascual E; Barskova V; Becce F; Castañeda-Sanabria J; Coyfish M; Guillo S; Jansen TL; Janssens H; Lioté F; Mallen C; Nuki G; Perez-Ruiz F; Pimentao J; Punzi L; Pywell T; So A; Tausche AK; Uhlig T; Zavada J; Zhang W; Tubach F; Bardin T
    Ann Rheum Dis; 2017 Jan; 76(1):29-42. PubMed ID: 27457514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lowering serum urate level to a guideline-based target is associated with a lower risk of incident fracture in people with gout: comment on the article by Wei et al.
    Wang G; Zhuo N; Yan D; Liu Z
    Arthritis Rheumatol; 2023 Oct; 75(10):1869-1870. PubMed ID: 37067524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.